Dare Bioscience, Inc. — Regulation A 1-A POS
Dare Bioscience, Inc. of SAN DIEGO, CA filed a Regulation A 1-A POS with the SEC on 2026-03-30. Aggregate offering: $24.3M (Tier 2). Industry: Other.
Offering
- Filed: 2026-03-30
- Form: 1-A POS
- Accession: 0001493152-26-013353
- Tier: Tier 2
- Total aggregate offering: $24.3M
- Issuer portion: $24.3M
- Price per security: $5.0000
- Securities offered: Equity (common or preferred stock), Option, warrant or other right to acquire another security, Security to be acquired upon exercise of option, warrant or other right to acquire security
- Broker-dealer CRD: 000166401
- Audit status: Audited
- Auditor: Haskell & White LLP
- Jurisdictions: 104 states/territories
Issuer
- CIK: 0001401914
- Organized in: DE
- Incorporated: 2005
- Address: 3655 NOBEL DRIVE, SAN DIEGO, CA, 92122
- Phone: 858-926-7655
- Employees: 21 full-time, 3 part-time
Financial snapshot (as filed)
- Total assets: $32.5M
- Cash & equivalents: $24.7M
- Total liabilities: $29.6M
- Stockholder equity: $2.8M
- Revenues: $1.0M
- Net income: $-13.4M
People (1)
| Name | Role | Location |
|---|
| Edwin Astudillo | Signer | SAN DIEGO, CA |
Other Reg A filings by this issuer (2)
More